Analysis of metastasis‑related risk factors and clinical relevance in adult soft‑tissue sarcoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new five-gene signature predicts survival in adult soft-tissue sarcoma (ASTS) by identifying metastatic risk. This model aids in personalized treatment strategies for ASTS patients.
Area Of Science
- Oncology
- Genomics
- Biomarker Discovery
Background
- Metastasis significantly impacts prognosis in adult soft-tissue sarcoma (ASTS), with a 2-year survival rate around 30%.
- Accurate prognostic models are crucial for personalized therapeutic strategies in ASTS.
- Identifying metastatic characteristics can improve survival predictions for ASTS patients.
Purpose Of The Study
- To develop and validate a prognostic prediction model for ASTS based on gene expression differences between metastatic and non-metastatic patients.
- To identify key genes associated with metastasis and survival in ASTS.
- To explore the functional implications of identified gene signatures in sarcoma progression.
Main Methods
- Differential gene expression analysis of Gene Expression Omnibus (GEO) and Cancer Genome Atlas (TCGA) datasets.
- Development of a five-gene prognostic signature (ACTG2, apolipoprotein D, coatomer protein complex subunit γ2 imprinted transcript 1, collagen type VI α6 chain, osteomodulin).
- Functional enrichment, pathway analysis (including PI3K-Akt), immune infiltration analysis, and in vitro assays (wound-healing, Transwell) to validate gene significance.
Main Results
- A five-gene signature was developed and validated, categorizing ASTS patients into high- and low-risk groups.
- High-risk patients showed activated stemness, extracellular matrix, cell adhesion, and PI3K-Akt pathways.
- Inhibition of ACTG2 reduced cell migration and invasion in a sarcoma cell line, confirming its role in metastasis.
Conclusions
- A validated metastasis-based prognostic model for ASTS has been successfully developed.
- This model accurately predicts survival and offers insights into sarcoma metastasis mechanisms.
- The findings support the design of tailored therapeutic regimens for ASTS patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...